Takuya Iyoda

Associate Professor

Sanyo-Onoda City University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Takuya Iyoda is an Associate Professor at Sanyo-Onoda City University, Japan. His research areas include the roles of matricellular proteins in cellular senescence, therapeutic potentials of bioactive peptides, and mechanisms of wound healing and cancer aggression. Recent publications highlight his work on macrophage transformation, atherosclerotic plaque formation, and targetable pathways in age-related diseases and cancer.

Articles (8)

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Hitoshi Shimano

Professor

University of Tsukuba

JAPAN

View details

Reiko Akagi

JAPAN

View details

Takehisa Hanawa

Professor

University of Tokyo

JAPAN

View details

Yoshimi Nakagawa

Professor

University of Toyama

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takuya Iyoda

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation

Involvement of Matricellular Proteins in Cellular Senescence: Potential Therapeutic Targets for Age-Related Diseases

Heat shock-induced heme oxygenase-1 expression in a mouse hepatoma cell line is dependent on HSF1 and modified by NRF2 and BACH1

Biofunctional Peptide FNIII14: Therapeutic Potential

Wound Healing Promotion by Hyaluronic Acid: Effect of Molecular Weight on Gene Expression and In Vivo Wound Closure

Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation

Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide

Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma

Collaborators (4)

Hitoshi Shimano

Reiko Akagi

Takehisa Hanawa

Yoshimi Nakagawa

Make your next move.